Cited by 17Microbial Metabolic Engineering and BioproductionBacterial Genetics and BiotechnologyMicrobial bioremediation and biosurfactants

Recent advances in synthetic biology toolkits and metabolic engineering of Ralstonia eutropha H16 for production of value-added chemicals

Wang, Ye, Tian, Yao, Xu, Dake, Cheng, Shaoan, Li, Wen-Wei, Song, Hao·2025·Biotechnology Advances

Abstract

Ralstonia eutropha H16, a facultative chemolithoautotrophic Gram-negative bacterium, demonstrates remarkable metabolic flexibility by utilizing either diverse organic substrates or CO 2 as the sole carbon source, with H 2 serving as the electron donor under aerobic conditions. The capacity of carbon and energy metabolism of R. eutropha H16 enabled development of synthetic biology technologies and strategies to engineer its metabolism for biosynthesis of value-added chemicals. This review firstly outlines the development of synthetic biology tools tailored for R. eutropha H16, including construction of expression vectors, regulatory elements, and transformation techniques. The availability of comprehensive omics data (i.e., transcriptomic, proteomic, and metabolomic) combined with the fully annotated genome sequence provides a robust genetic framework for advanced metabolic engineering. These advancements facilitate efficient reprogramming metabolic network of R. eutropha. The potential of R. eutropha as a versatile microbial platform for industrial biotechnology is further underscored by its ability to utilize a wide range of carbon sources for the production of value-added chemicals through both autotrophic and heterotrophic pathways. The integration of state-of-the-art genetic and genomic engineering tools and strategies with high cell-density fermentation processes enables engineered R. eutropha as promising microbial cell factories for optimizing carbon fluxes and expanding the portfolio of bio-based products.

Integrity signals

Registry

Crossref · 10.1016/j.biotechadv.2025.108516

Cites

356 of 356 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Any future advancement of 5-G biofuels from the current conceptual stage is entirely contingent upon extensive and high-risk fundamental research and development across numerous areas, including advanced synthetic biology toolkits, breakthroughs in metabolic engineering, new reactor designs, efficient CO2 capture and delivery systems, robust LCA methodologies, and resolving challenges related to长期

    “Any future advancement from the current conceptual stage is entirely contingent upon extensive and high-risk fundamental research and development across numerous areas.These include significantly more advanced synthetic biology toolkits, breakthroughs in metabolic engineering for precise and efficient target molecule synthesis, entirely new reactor designs for these novel bioprocesses, highly”
  • Third-generation (algal) and later-generation biofuels remain largely in R&D, with current production costs significantly higher than other options.

    “Third-generation (algal [392]) and later-generation biofuels remain largely in R&D, with current production costs significantly higher than other options [179,180,187].”

Cites

Flagged first, then by citations

7 of the 363 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Wang, Y., Tian, Y., Xu, D., Cheng, S., Li, W.-W., & Song, H.
Affiliations
  • Tianjin University (CN)
  • Shenyang National Laboratory for Materials Science (CN)
  • Zhejiang University (CN)
  • University of Science and Technology of China (CN)
Corresponding author
Song, Hao
Venue
Biotechnology Advances
Publisher
Elsevier BV
Published
2025-03
Volume
79
Pages
108516
ISSN
0734-9750 (ISSN-L)
OpenAlex
W4406229950
Cited by
17
References
363
Citations by year
2026: 12 · 2025: 5
FWCI
1.49
Type
journal article
Language
en
Open access
closed
Locations
  • Biotechnology Advances (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Key Technologies Research and Development Program
  • National Natural Science Foundation of China
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Microbial Metabolic Engineering and Bioproduction
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
  • Physical Sciences › Environmental Science › Pollution › Microbial bioremediation and biosurfactants
Keywords
Ralstonia eutropha H16, synthetic biology toolkit, metabolic engineering, value-added chemicals, expression vectors, regulatory elements, transformation techniques, carbon metabolism, energy metabolism, omics data, genome annotation, microbial cell factories, bioproducts, industrial biotechnology
MeSH terms
Cupriavidus necator, Synthetic Biology, Metabolic Engineering

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review